Viewing Study NCT05608135


Ignite Creation Date: 2025-12-24 @ 10:21 PM
Ignite Modification Date: 2025-12-28 @ 7:09 PM
Study NCT ID: NCT05608135
Status: RECRUITING
Last Update Posted: 2023-03-10
First Post: 2022-09-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: AI-based Multi-center Research on Identification/Classification/Aided Diagnosis of Mood Disorder
Sponsor: First Affiliated Hospital of Zhejiang University
Organization:

Study Overview

Official Title: Recognition/Classification/Auxiliary Diagnosis of Affective Disorder Based on AI:A Multi-center Study
Status: RECRUITING
Status Verified Date: 2023-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: At present, diagnosis and recognition of depression and bipolar disorder are mainly based on subjective evidence such as clinical interview and scale evaluation. The corresponding diagnosis basis has some shortcomings, such as poor diagnostic reliability and failure in early identification of bipolar disorder. Therefore, it is of great significance to explore objective diagnostic indicators to remedy the deficiencies.

Therefore,the investigators collect psychological and physiological information data of patients with bipolar disorder and depression.Then the investigators aim to construct and verify the multidimensional emotion recognition model to analyze the personality characteristics, negative emotions and cognitive reactions of different individuals, and form a systematic accurate recognition and evaluation tool.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: